VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $713 | -13.0% | 26,508 | -2.7% | 0.04% | -10.3% |
| Q2 2023 | $820 | -1.3% | 27,234 | +6.0% | 0.04% | -7.1% |
| Q1 2023 | $831 | -4.4% | 25,687 | -15.3% | 0.04% | -12.5% |
| Q4 2022 | $869 | -99.9% | 30,315 | -3.6% | 0.05% | +11.6% |
| Q3 2022 | $759,000 | -46.8% | 31,455 | -39.6% | 0.04% | -44.9% |
| Q2 2022 | $1,426,000 | -4.7% | 52,067 | +33.4% | 0.08% | +13.0% |
| Q1 2022 | $1,497,000 | +4.2% | 39,044 | -13.0% | 0.07% | +11.3% |
| Q4 2021 | $1,437,000 | +4.3% | 44,872 | -4.0% | 0.06% | -4.6% |
| Q3 2021 | $1,378,000 | -19.3% | 46,746 | -6.9% | 0.06% | -19.8% |
| Q2 2021 | $1,707,000 | +20.0% | 50,227 | +14.8% | 0.08% | +2.5% |
| Q1 2021 | $1,422,000 | -14.5% | 43,761 | -5.3% | 0.08% | -45.9% |
| Q4 2020 | $1,664,000 | -23.7% | 46,196 | -17.0% | 0.15% | -30.1% |
| Q3 2020 | $2,180,000 | +85.4% | 55,677 | +73.7% | 0.21% | +88.3% |
| Q2 2020 | $1,176,000 | +95.7% | 32,052 | +22.8% | 0.11% | +54.2% |
| Q1 2020 | $601,000 | -22.9% | 26,102 | -2.0% | 0.07% | +4.3% |
| Q4 2019 | $780,000 | +35.4% | 26,634 | +23.6% | 0.07% | +23.2% |
| Q3 2019 | $576,000 | -9.4% | 21,553 | -13.3% | 0.06% | -12.5% |
| Q2 2019 | $636,000 | -0.2% | 24,872 | -12.5% | 0.06% | -5.9% |
| Q1 2019 | $637,000 | +53.1% | 28,426 | +44.1% | 0.07% | +28.3% |
| Q4 2018 | $416,000 | +2.2% | 19,732 | -10.1% | 0.05% | +15.2% |
| Q3 2018 | $407,000 | -25.9% | 21,949 | -10.9% | 0.05% | -32.4% |
| Q2 2018 | $549,000 | -1.1% | 24,629 | -2.5% | 0.07% | -5.6% |
| Q1 2018 | $555,000 | -5.8% | 25,261 | -0.3% | 0.07% | 0.0% |
| Q4 2017 | $589,000 | +3.7% | 25,336 | +2.4% | 0.07% | -2.7% |
| Q3 2017 | $568,000 | +3.1% | 24,736 | -1.0% | 0.07% | +4.2% |
| Q2 2017 | $551,000 | +7.0% | 24,977 | +10.7% | 0.07% | +1.4% |
| Q1 2017 | $515,000 | +0.8% | 22,562 | -7.6% | 0.07% | -6.7% |
| Q4 2016 | $511,000 | -26.7% | 24,415 | -7.4% | 0.08% | -27.9% |
| Q3 2016 | $697,000 | +54.5% | 26,355 | +62.1% | 0.10% | +40.5% |
| Q2 2016 | $451,000 | – | 16,263 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |